MICHELLE FLORES: Open Payments
NPI 1629522438 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,911 in 182 payments from 20 companies in 2025. Trend: 2023 $4,028 · 2024 $3,708 · 2025 $2,911
Food & beverage: $2,826Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $535 |
| Incyte Corporation | 26 | $350 |
| Janssen Biotech, Inc. | 26 | $325 |
| GENZYME CORPORATION | 8 | $239 |
| UCB, Inc. | 9 | $223 |
| Galderma Laboratories, L.P. | 14 | $186 |
| E.R. Squibb & Sons, L.L.C. | 16 | $181 |
| Regeneron Healthcare Solutions, Inc. | 6 | $173 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $114 |
Products named: DUPIXENT, OPZELURA, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, Sotyktu, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
